Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren + hydrochlorothiazide vs aliskiren in Stage II hypertension (12-week)
2008-000862-21Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertension (HTN) comparing Aliskiren + hydrochlorothiazide with Aliskiren monotherapy (2 arms). Primary endpoint: Change from baseline in mean sitting systolic blood pressure at Week 12. Started Apr 2008; status: completed.
02
Drugs
aliskirenhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2008-000862-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000862-21.